TRACK-TBI Longitudinal Biomarker Study
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Austin, Charlestown, Cincinnati, Dallas, Houston, Philadelphia, Pittsburgh, Richmond, Salt Lake City, San Francisco, and Seattle, United StatesSee the 11 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 300 people, planned
- Started
- 1 Mar 2022
- Expected to end
- 28 Feb 2027
- Type of study
- Observational, 3 groups
- Treatments tested
- Telephone Outcome Assessment
- In-Person Outcome Assessment
- 3T Magnetic Resonance Imaging (MRI)
- Blood Draw
- Record updated
- 17 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- LONGITUDINAL Telephone Assessment:
- Participated in TRACK-TBI,
- At least two years post injury, and
- Completed at least 1 GOSE during the TRACK-TBI follow-up assessments
- LONGITUDINAL BIOMARKER In-Person Assessment:; Must complete at least one Longitudinal Telephone Assessment and fall into one of the following groups:
- Group 1- Completed TRACK-TBI 6M MRI and are stable or improved with regard to Criteria for Establishing Decline
- Group 2- Criteria for Establishing Decline met when comparing the Telephone Assessments to the last completed TRACK-TBI assessment
- Group 3- All TRACK-TBI orthopedic controls; Ability of participant or legally authorized representative to provide informed consent
Who cannot take part
- Dementia diagnosed prior to the index TBI
Where in United States
- University of Texas at AustinAustin, United States
- Spaulding Rehabilitation HospitalCharlestown, United States
- University of CincinnatiCincinnati, United States
- University of Texas, SouthwesternDallas, United States
- Baylor College of MedicineHouston, United States
- University of Pennsylvania/Penn Presbyterian Medical CenterPhiladelphia, United States
- University of PittsburghPittsburgh, United States
- Virginia Commonwealth UniversityRichmond, United States
- University of UtahSalt Lake City, United States
- University of California San FranciscoSan Francisco, United States
- University of WashingtonSeattle, United States
About the trial
What the trial wants to find out
The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
The 3 groups in the trial
- Telephone Assessment Battery
TRACK-TBI participants may complete up to three annual telephone calls to assess outcome status. These assessments will determine eligibility for the in-person study visit.
Treatment: Telephone Outcome Assessment
- Comprehensive Assessment Battery (CAB)
Participants who demonstrate decision-making capacity will be asked to complete the Comprehensive Assessment Battery (CAB). The CAB in-person is comprised of measures of cognition (i.e. attention, memory, information processing speed, executive functions), mood (i.e., depression, anxiety), social participation, subjective well-being, post-traumatic stress, interviews, global functional status measures, and a COVID-19 questionnaire.
Treatment: Telephone Outcome Assessment, In-Person Outcome Assessment, 3T Magnetic Resonance Imaging (MRI), and Blood Draw
- Abbreviated Assessment Battery (AAB)
Participants who do not have decision-making capacity will be asked to complete a modified assessment battery, called the Abbreviated Assessment Battery (AAB). The AAB in-person assessment will administer the Speech Intelligibility, GOAT, and CAP and/or CRS-R to study participants.
Treatment: Telephone Outcome Assessment, In-Person Outcome Assessment, 3T Magnetic Resonance Imaging (MRI), and Blood Draw
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI)- a Longitudinal Biomarker Study
- Record updated
- 17 August 2026